Kezar Life Sciences
76 hedge funds and large institutions have $243M invested in Kezar Life Sciences in 2021 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 28 increasing their positions, 22 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
1% more funds holding
Funds holding: 75 → 76 (+1)
0.08% more ownership
Funds ownership: 5.75% → 5.83% (+0.08%)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
76
Holding in Top 10
1
Calls
$1.01M
Puts
$10K
Top Buyers
| 1 | +$11.9M | |
| 2 | +$3.92M | |
| 3 | +$1.72M | |
| 4 |
Goldman Sachs
New York
|
+$1.04M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$894K |
Top Sellers
| 1 | -$5.22M | |
| 2 | -$3.79M | |
| 3 | -$2.61M | |
| 4 |
Morgan Stanley
New York
|
-$2.41M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$2.08M |